Clinical trial
Shanghai Cognitive Impairment Study of the Elderly Population: YuGarden Cohort
NCT06325527 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Shanghai Cognitive Impairment Study of the Elderly Population: YuGarden Cohort
- Lead sponsor
- Ruijin Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2024
- Completion date
- June 1, 2031
- Enrollment
- 1,872 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, cognitive impairment, mild cognitive impairment, neurodegenerative diseases